New onset of type 2 diabetes mellitus with feminizing hormone therapy: Case series

International Journal of Transgenderism

Volumn 6, Issue 2, 2002, Pages

  Feldman, Jamie ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Estrogen; Transgender; Type 2 diabetes mellitus

Indexed keywords

ATENOLOL; CONJUGATED ESTROGEN; DIGOXIN; ESTRADIOL; FINASTERIDE; FLUOXETINE; GEMFIBROZIL; METFORMIN; NORETHISTERONE; PIOGLITAZONE; PIPERAZINE ESTRONE SULFATE; QUINIDINE; SERTRALINE; SEX HORMONE; SIMVASTATIN; SPIRONOLACTONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; FAMILY HISTORY; FEMALE; FEMINIZATION; FOLLOW UP; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOME MONITORING; HORMONAL THERAPY; HUMAN; LABORATORY TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PHYSICAL EXAMINATION; RISK FACTOR; SCREENING; TRANSSEXUALISM; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 3943109496     PISSN: 14344599     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. American Diabetes Association (2001) Screening for Diabetes, Diabetes Care, 24(21): 1-8.
2. Blanchard, R. (1994) A structural equation model for age at clinical presentation in nonhomosexual male gender dysphorics. Archives of Sexual Behavior, 23(3): 311-320.
3. Centers for Disease Control and Prevention. (1997) Trends in the prevalence and incidence of self-reported diabetes mellitus - United States. Morbidity and Mortality Weekly Report, 46(43): 1014-1018.
4. Chasan-Taber, L., Willett, W.C., Stampfer, M.J., Hunter, D.J., Colditz, G.A., Spiegelman, D., and Manson, J.E. (1997) A prospective study of oral contraceptives and NIDDM among U.S. women. Diabetes Care, 20(3): 330-335.
5. Christiensen, L., Hagen, C., Henriksen, J.E., and Haug, E. (1997) Elevated levels of sex hormones and sex hormone binding globulin in male patients with insulin dependent diabetes mellitus. Effect of improved blood glucose regulation. Danish Medical Bulletin, 44(5): 547-550.
6. Cornu, C., Mercier, C., Ffrench, P., Bully, C., Pugeat, M., Cousin, P., Riou, J.P., Bajart, L., Orgiazzi, J., Pimmet-Nicot, C., Darsy, P., Boissel, J.P., and Berthezen, F. (2000) Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial. Maturitas, 37(2): 95-104.
7. Espeland, M.A., Hogan P.E., Fineberg, S.E., Howard, G., Schrott, H., Waclawiw, M.A., and Bush T.L. (1998) Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Diabetes Care, 21(10): 1589-1595.
8. Fineberg, S.E. (2000) Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progesterone Intervention (PEPI) study. Drugs and Aging, 17(6): 453-461.
9. Giltay, E.J., Elbers J.M., Gooren L.J., Emeis J.J., Kooistra T., Asscheman H., and Stehouwer (1998) Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arteriosclerosis Thrombosis & Vascular Biology, 18(11): 1716-1722.
10. Godsland, I.F., Gangar, K., Walton, C., Cust, M.P., Whitehead, M.I., Wynn, V., and Stevenson, J.C. (1993) Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism: Clinical and Experiemental, 42(7) L846-853.
11. Gonzalez-Ortiz, M., Martinez-Abundis, E., and Lifshiz, A. (1998) Insulin sensitivity and sex steroid hormone levels during the menstrual cycle in healthy women with non-insulin-dependent diabetic parents. Gynecologic and Obstetric Investigations, 46(3): 187-190.
12. Goodman-Gruen, D. and Barrett-Connor, E. (2000) Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care, 23(7): 912-918.
13. Harvengt, C. (1992) Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus. Diabete et Metabolisme, 18(2): 71-77.
14. Lobo, R.A. (1987) Absorption and metabolic effects of different types of estrogen and progestogens. Obstetrics and Gynecology Clinics of North America, 14(1): 143-167.
15. Manson, J.E., Rimm, E.B., Colditz, G.A., Willett, W.C., Nathan, D.M., Arky, R.A., Rosner, B., Hennekens, C.H., Speizer, F.E., and Stampfer, M.J. (1992) A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Annals of Epidemiology, 2(5): 665-673.
16. Meyer, W.J., Webb, A., Stuart, C.A., Finkelstein, J.W., Lawrence, B., and Walker, P.A. (1986) Physical and hormonal evaluation of transsexual patients: a longitudinal study. Archives of Sexual Behavior, 15(2): 12-38.
17. Nader, S., Riad-Gabriel, M.G., and Saad, M.F. (1997) The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women. Journal of Clinical Endocrinology and Metabolism, 82(9): 3074-3077.
18. O'Connell, M. (1995). Pharmacokinetic and pharmacologic variation between different estrogen products. Journal of Clinical Pharmacology, 35:18S-24S.
19. Petersen, K.R., Skouby, S.O., Vedel, P., and Haaber, A.B. (1995) Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism. Diabetes Care, 18(6): 800-806.
20. Rimm, E.B., Manson J.E., Stampfer, M.J., Colditz, G.A., Wilett, W.C., Rosner, B., Hennekens, CH., and Speizer, F.E. (1992) Oral contraceptive use and the risk of type 2 diabetes mellitus in a large prospective study of women. Diabetologia, 35(10): 967-972.
21. Russel-Briefel, R., Ezzatti, T.M., Perlman, J.A., and Murphy, R.S. (1987) Impaired glucose tolerance in women using oral contraceptives: United States, 1976-80. Journal of Chronic Diseases, 40(1): 3-11.
22. Schlatterer, K., Yassouridis, A., von Werder, K., Poland, D., Kemper, J., and Stalla, G. (1998) A follow-up study for estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients. Archives of Sexual Behavior, 27(5): 475-492.
23. Van Kesteren, P.J., Asscheman, H., Megens, J.A., and Gooren, L.J. (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology (Oxford), 47: 337-342.